West Price To Sales Ratio from 2010 to 2024
| WST Stock | USD 354.11 2.59 0.74% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 8.8692508 | Current Value 9.31 | Quarterly Volatility 3.50463925 |
Check West Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among West main balance sheet or income statement drivers, such as Depreciation And Amortization of 144.2 M, Total Revenue of 3.1 B or Gross Profit of 1.2 B, as well as many exotic indicators such as Price To Sales Ratio of 9.31, Dividend Yield of 0.0021 or PTB Ratio of 9.54. West financial statements analysis is a perfect complement when working with West Pharmaceutical Valuation or Volatility modules.
West | Price To Sales Ratio |
Latest West Pharmaceutical's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of West Pharmaceutical Services over the last few years. Price to Sales Ratio is figured by comparing West Pharmaceutical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on West Pharmaceutical sales, a figure that is much harder to manipulate than other West Pharmaceutical Services multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. West Pharmaceutical's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in West Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 9.43 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
West Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 5.14 | |
| Geometric Mean | 3.98 | |
| Coefficient Of Variation | 68.16 | |
| Mean Deviation | 2.87 | |
| Median | 4.22 | |
| Standard Deviation | 3.50 | |
| Sample Variance | 12.28 | |
| Range | 11.2503 | |
| R-Value | 0.88 | |
| Mean Square Error | 2.89 | |
| R-Squared | 0.78 | |
| Significance | 0.000012 | |
| Slope | 0.69 | |
| Total Sum of Squares | 171.95 |
West Price To Sales Ratio History
About West Pharmaceutical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include West Pharmaceutical income statement, its balance sheet, and the statement of cash flows. West Pharmaceutical investors use historical funamental indicators, such as West Pharmaceutical's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although West Pharmaceutical investors may use each financial statement separately, they are all related. The changes in West Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on West Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on West Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in West Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 8.87 | 9.31 |
Pair Trading with West Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if West Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in West Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to West Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace West Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back West Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling West Pharmaceutical Services to buy it.
The correlation of West Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as West Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if West Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for West Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of West Pharmaceutical Correlation against competitors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for West Stock analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is West Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Dividend Share 0.78 | Earnings Share 7.59 | Revenue Per Share 39.549 | Quarterly Revenue Growth (0.03) |
The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.